At the time of writing, Beta Bionics Inc [BBNX] stock is trading at $17.24, up 12.24%. An important factor to consider is whether the stock is rising or falling in short-term value. The BBNX shares have gain 11.15% over the last week, with a monthly amount glided 56.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Beta Bionics Inc [NASDAQ: BBNX] stock has seen the most recent analyst activity on May 30, 2025, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $20. Previously, Goldman started tracking the stock with Neutral rating on May 30, 2025, and set its price target to $16. On February 24, 2025, Stifel initiated with a Buy rating and assigned a price target of $25 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $26 on February 24, 2025. Leerink Partners initiated its recommendation with a Outperform and recommended $28 as its price target on February 24, 2025. Lake Street started tracking with a Buy rating for this stock on February 24, 2025, and assigned it a price target of $30. In a note dated February 24, 2025, BofA Securities initiated an Buy rating.
For the past year, the stock price of Beta Bionics Inc fluctuated between $8.89 and $24.50. Beta Bionics Inc [NASDAQ: BBNX] shares were valued at $17.24 at the most recent close of the market.
Analyzing the BBNX fundamentals
Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at -0.77%, Pretax Profit Margin comes in at -1.02%, and Net Profit Margin reading is -1.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.57 and Total Capital is -0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.65 points at the first support level, and at 14.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.11, and for the 2nd resistance point, it is at 18.98.
Ratios To Look Out For
It is important to note that Beta Bionics Inc [NASDAQ:BBNX] has a current ratio of 15.88. On the other hand, the Quick Ratio is 14.93, and the Cash Ratio is 2.57.
Transactions by insiders
Recent insider trading involved Mensinger Mike, Chief Product Officer, that happened on Jan 31 ’25 when 33350.0 shares were purchased. Chief Product Officer, Mensinger Mike completed a deal on Jan 31 ’25 to sell 13.0 shares. Meanwhile, 10% Owner Wellington Hadley Harbor Aggre bought 1.0 million shares on Jan 31 ’25.
